KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2017 - 2025)

Historic Interest Coverage Ratio for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 72.12.

  • Regeneron Pharmaceuticals' Interest Coverage Ratio fell 2352.14% to 72.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 81.69, marking a year-over-year increase of 1299.11%. This contributed to the annual value of 81.69 for FY2025, which is 1299.11% up from last year.
  • As of Q4 2025, Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 72.12, which was down 2352.14% from 53.2 recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 299.86 during Q2 2025, with a 5-year trough of 46.67 in Q1 2024.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 74.24 (2021), whereas its average is 98.15.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Interest Coverage Ratio crashed by 6479.51% in 2022 and then skyrocketed by 31491.63% in 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 187.21 in 2021, then plummeted by 64.8% to 65.91 in 2022, then fell by 19.34% to 53.16 in 2023, then soared by 77.38% to 94.3 in 2024, then fell by 23.52% to 72.12 in 2025.
  • Its Interest Coverage Ratio stands at 72.12 for Q4 2025, versus 53.2 for Q3 2025 and 299.86 for Q2 2025.